After psilocybin and ketamine, a new biotech comes along developing a drug Scott Gottlieb fought

July 10, 2020 Articles 12:52 pm

Andrew Kruegel was six years into his chemistry work at Columbia University, when, one day in August 2016, he learned he might have only 30 days before the government made him destroy his research.

JOIN OUR MAILING LIST

Sign up to receive the latest news on atai.

Email
submit